Journals / Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2011 / Cilt: 51 - Sayı: 3

Sekonder osteoporoz tanısı atlanıyor mu?

Pages
142–145
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We wanted to present a patient who applied to a private hospital with low back pain 6 mount ago and according to the dual energy Xray Absorptiometry (DEXA) measurement diagnosed as osteoporoses and bisphosphonate treatment was started and then diagnosed as multiple myeloma in our internal medicine department.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Osteoporosis; the weakening of the bone due to a decrease in bone mass, is a skeletal disease that increase the risk of fractures especially in the spine, hip and wrist.
📊
Key Findings & Data:Diagnosis of osteoporosis often is reduced in postmenopausal or senile osteoporosis, in patients with low bone mineral density (BMD) therapy is started with the diagnosis of primary osteoporosis.
💡
Conclusion & Impact:We wanted to present a patient who applied to a private hospital with low back pain 6 mount ago and according to the dual energy Xray Absorptiometry (DEXA) measurement diagnosed as osteoporoses and bisphosphonate treatment was started and then diagnosed as multiple myeloma in our internal medicine department.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Osteoporosis; the weakening of the bone due to a decrease in bone mass, is a skeletal disease that increase the risk of fractures especially in the spine, hip and wrist. Diagnosis of osteoporosis often is reduced in postmenopausal or senile osteoporosis, in patients with low bone mineral density (BMD) therapy is started with the diagnosis of primary osteoporosis. This situation leads to delay the diagnosis of secondary osteoporosis or causes to be bypassed. We wanted to present a patient who applied to a private hospital with low back pain 6 mount ago and according to the dual energy Xray Absorptiometry (DEXA) measurement diagnosed as osteoporoses and bisphosphonate treatment was started and then diagnosed as multiple myeloma in our internal medicine department.

Özet

Osteoporoz; kemik kitlesinde azalmaya bağlı olarak, kemiğin zayıflaması, özellikle vertebra, kalça ve el bileğinde kırık riskinde artışa yol açan bir iskelet sistemi hastalığıdır. Osteoporoz tanısı sıklıkla postmenopozal veya senil osteoporoza indirgenmiş olup, kemik mineral yoğunluğu (KMY) düşük olan hastalar primer osteoporoz tanısı ile tedavi edilmektedir. Bu durum sekonder osteoporoz nedenlerinin atlanmasına veya tanısının konulmasında gecikmelere neden olmaktadır. Altı ay önce bel ağrısı şikayetiyle özel bir hastaneye başvuran, yapılan Dual Enerji X-ray Absorpsiyometre (DEXA) ölçümü sonrası osteoporoz tanısı konularak bifosfonat başlanan ancak iç hastalıkları kliniğimizde multipl miyelom tanısı konulan bir olguyu sunmak istedik.

🔖

Cite This Article

KARATOPRAK, C., KAYATAŞ, K., YOLBAŞ, S., KILIZASLAN, H., BALTA, M., UYAR, S., DEMİRTUNÇ, R. (2022). Sekonder osteoporoz tanısı atlanıyor mu?. Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 51 - Sayı: 3, 142–145. https://ajindex.com/articles/535431

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. National Ostoporosis Foundation. Phisician's guide to prevention and treatment of osteoporosis. Washington(DC): National Osteoporosis Foundation; 1998 2. Eastell R. Treatment of potmenopausal osteoporosis. N Engl J M 338: 737-746, 1998. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. JAMA 2001;285:785-95. 3. Raisz L. "Pathogenesis of osteoporosis: concepts, conflicts, and prospects."J Clin Invest 2005;115 (12): 3318-25. 4. Simonelli C, et al. Diagnosis and Treatment of Osteoporosis, 5th edition, ICSI Health Care Gudline(PDF). Institute for Clinical Systems Improvement. Retrieved 2008-04-08. 5. Ebeling PR. Clinical practice. Osteoporosis in men. N Engl J Med. 2008: 358 (14): 1474-82. 6. Brown JP, Josse RG. CMAJ, 2002;167:S1-S34 7. Tannenbaum C, Clark J, Schwartzman K, et al. Yield of laboratory, testing to identify seondarycontributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 2002;87:4431-7. 8. JamalSA, Letter RE, BayoumiAM, etal. Clinical utility of laboratory testing in women with osteoporosis. Osteoporos Int 2005;16:534-40. 9. Genant H.K, Engelke K, Fuerst T, et al. Noninvasive assesment of bone mineral and structure: state of the art. J. Bone Miner Res 1996;11:707-30. 10. Miller PD, Bonnick SL, Rosen CJ, Consensus of an international panel on the clinical utulity of bone mass measurements in the detection of low bone mass in the adult population. Calif Tissue int 1996;58:207-14